Human LRRC53 CRISPR gRNA in Lenti Particles
gRNA
GEEN, PExp
Lentiviral Vector
pLenti-U6-sgRNA-PGK-Neo
Ampicillin
U6 Promoter
unconjugated
Stable
Catalog No. ABIN5176892
Quick Overview for Human LRRC53 CRISPR gRNA in Lenti Particles (ABIN5176892)
Gene
LRRC53
(Leucine Rich Repeat Containing 53 (LRRC53))
Application
Genome Editing with Engineered Nucleases (GEEN), Protein Expression (PExp)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Individual gRNA against LRRC53 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with an individual gRNA (300 μL) for a specific sequence of LRRC53
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- LRRC53 (Leucine Rich Repeat Containing 53 (LRRC53))
-
Alternative Name
- LRRC53
Target
-
You are here:
